描述

DNA vaccines are third-generation vaccines. They contain DNA that codes for specific proteins (antigens) from a pathogen. DNA vaccines have emerged as a safer alternative to standard live and inactivated vaccines for treating human and animal viral diseases. They exhibit several advantages over traditional strategies in terms of safety, stability, ease of manufacturing, and immunogenicity. The global DNA vaccines market is poised to grow by US$ 14,948.0 百万来自 2022 到 2028, 复合年增长率为 30.1% 在预测期内, 根据StrategyHelix.

该报告提供了该时期的最新市场规模数据 2018-2021 并预测到 2028 covering key market aspects like sales value for DNA vaccines. The global DNA vaccines market is segmented on the basis of type, 应用, 和最终用户. 按类型, the global DNA vaccines market has been segmented into clinical applications, research tools. The research tools segment was the largest contributor to the global DNA vaccines market in 2021. 根据申请, the global DNA vaccines market is categorized into genetic immunization, pDNA formulations. 据研究, the genetic immunization segment had the largest share in the global DNA vaccines market. 基于最终用户, the global DNA vaccines market has been segmented into animal health, biodefense, cancers, infectious diseases, 其他的. The cancers segment held the largest revenue share in 2021.

The global DNA vaccines market is highly competitive. Some of the leading companies operating in the market are Astellas Pharma Inc., AstraZeneca plc, Bristol Myers Squibb Company (BMS), Gilead Sciences Inc., 约翰逊 & 约翰逊, Merck KGaA, Novartis International AG, Pfizer Inc., 赛诺菲公司.

该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the DNA vaccines market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.

报告范围

类型: clinical applications, research tools
应用: genetic immunization, pDNA formulations
最终用户: animal health, biodefense, cancers, infectious diseases, 其他的
考虑的年数: 本报告涵盖期间 2018 到 2028

利益相关者的主要好处

– Get a comprehensive picture of the global DNA vaccines market
– 根据当地数据确定区域战略和战略重点
– 精准定位增长领域和投资趋势

目录

部分 1. 介绍
– 研究范围
– 学习时段
– 地理范围
– 研究方法论
部分 2. DNA vaccines market overview
部分 3. Market breakdown by type
– Clinical applications
– Research tools
部分 4. 按应用划分的市场细分
– Genetic immunization
– PDNA formulations
部分 5. 按最终用户划分的市场细分
– Animal health
– Biodefense
– Cancers
– Infectious diseases
– 其他的
部分 6. 重点企业
– Astellas Pharma Inc.
– AstraZeneca plc
– Bristol Myers Squibb Company (BMS)
– Gilead Sciences, 公司.
– 约翰逊 & 约翰逊
– Merck KGaA
– Novartis International AG
– Pfizer Inc.
– 赛诺菲公司.
关于StrategyHelix
免责声明